AmirAli Talasaz, Co-Chief Executive Officer at Guardant Health, Inc. (GH), sold 260,000 shares at $150.49 ($39.3M) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Open-market sale of $39.3M GH by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.49 | 64,037 | $9.6M | 24.5% |
| 2 | $151.16 | 52,935 | $8.0M | 20.4% |
| 3 | $150.53 | 25,812 | $3.9M | 9.9% |
| 4 | $151.47 | 70,513 | $10.7M | 27.2% |
| 5 | $152.20 | 46,663 | $7.1M | 18.1% |
| 6 | $153.00 | 40 |
| $6K |
| 0.0% |
| Total | $151.20 avg | 260,000 | $39.3M | 100% |
| Filing → |
| GH | SELL | 2026-05-13 | $5.0M | — | Filing → |
| GH | SELL | 2025-12-10 | $8.5M | — | Filing → |
| GH | SELL | 2025-07-02 | $10.2M | — | Filing → |